CERT vs BTSG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CERT · Certara$12.05 ▼ 1.07%
BTSG · BrightSpring Health Services$67.15 ▲ 1.96%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CERT +39.8%
- BTSG +100.0%
Head to head
| Metric | CERT | BTSG |
|---|---|---|
| Price | $12.05 | $67.15 |
| Change today | ▼ 1.07% | ▲ 1.96% |
| Market cap | $1.84B | $13.36B |
| Return, 3 months | +49.3% | +9.3% |
| Return, year to date | +36.8% | +79.3% |
| Return, 1 year | +39.0% | +102.6% |
| P/E (TTM) | -28.7 | 36.1 |
| P/B | 1.9 | 6.1 |
| P/E percentile vs own 5y | 66th | 58th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +1.0% | +26.4% |
| Net profit growth (YoY) | -2,708.4% | +81.6% |
| Gross margin | 61.6% | 12.5% |
| Operating margin | 0.6% | 3.4% |
| Net margin | -16.2% | 2.7% |
| Return on equity | -6.7% | 20.5% |
| Analyst target vs. price | -12.9% | +18.0% |
| Analyst buy share | 33% | 100% |
| RSI (14) | 71 | 60 |
| 30-day volatility | 57.8% | 46.4% |
| Max drawdown, 1 year | -64.2% | -23.6% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BTSG is the largest of the group by market value.
- BTSG has returned the most over the past year.
- CERT carries the lowest trailing P/E.
- BTSG is growing revenue fastest.
- BTSG keeps the most profit per dollar of sales.
- BTSG has been the calmest stock over the last 30 days.